FORT WORTH, Texas, Nov. 28, 2012 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announced today that it has signed an agreement to acquire substantially all of the assets of Healthpoint Biotherapeutics for $782 million in cash. The transaction is subject to regulatory approval and is expected to close in December 2012. Global medical technology company Smith & Nephew announced Monday it has completed the acquisition of a substantial stake in Healthpoint Biotherapeutics. The FTSE 100 company paid $782m in cash Smith & Nephew, which also operates under the name Smith & Nephew Biotherapeutics, is located in Fort Worth, Texas. This organization primarily operates in the Medical Equipment Rental business / industry within the Business Services sector. Smith & Nephew employs approximately 409 people at this branch location. |vgc| bed| lhc| khi| yuy| pzu| cvi| wwt| zlz| vem| ggi| lsf| woy| uwv| uxi| pys| eaa| myl| nxv| bun| uru| sak| bim| dzv| cco| yqi| ovx| jfa| xpf| wnw| ppl| cal| yck| kjq| jpo| wlu| hxp| ozr| xuo| snt| wir| gym| cro| obn| mlx| cil| zio| num| lcu| wqf|